Correction: A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients

• Wei Bai,
• Fan Yang,
• Huji Xu,
• Wei Wei,
• Hongbin Li,
• Liyun Zhang,
• Yi Zhao,
• Xiaofei Shi,
• Yan Zhang,
• Xiaofeng Zeng,
• Xiaomei Leng

Affiliations

Wei Bai

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education

Fan Yang

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education

Huji Xu

Department of Rheumatology and Immunology, Changzheng Hospital, Naval Medical University

Wei Wei

Department of Rheumatology and Immunology, Tianjin Medical University General Hospital

Hongbin Li

Department of Rheumatology, The Afliated Hospital of Inner Mongolia Medical University

Liyun Zhang

Department of Rheumatology, Third Hospital of Shanxi Medical University, Bethune Hospital Shanxi Academy of Medical Sciences

Yi Zhao

Department of Rheumatology and Allergy, Xuanwu Hospital, Capital Medical University

Xiaofei Shi

Department of Rheumatology and Immunology, The First Afliated Hospital and College of Clinical Medicine, Henan University of Science and Technology

Yan Zhang

Department of Rheumatology and Immunology, Tangdu Hospital, Fourth Military Medical University (Air Force Medical University)

Xiaofeng Zeng

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education

Xiaomei Leng

Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education